Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL, Doré BT, Momparler LF. Momparler RL, et al. Among authors: momparler lf. Cancer Lett. 1990 Oct 8;54(1-2):21-8. doi: 10.1016/0304-3835(90)90086-d. Cancer Lett. 1990. PMID: 1698532
Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
Raynal NJ, Charbonneau M, Momparler LF, Momparler RL. Raynal NJ, et al. Among authors: momparler lf, momparler rl. Oncol Res. 2008;17(5):223-30. doi: 10.3727/096504008786111356. Oncol Res. 2008. PMID: 18980019
Antileukemic activity of genistein, a major isoflavone present in soy products.
Raynal NJ, Momparler L, Charbonneau M, Momparler RL. Raynal NJ, et al. Among authors: momparler l, momparler rl. J Nat Prod. 2008 Jan;71(1):3-7. doi: 10.1021/np070230s. Epub 2007 Dec 29. J Nat Prod. 2008. PMID: 18163589
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL. Lemaire M, et al. Among authors: momparler lf, momparler rl. Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6. doi: 10.1007/s00280-008-0750-6. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398609
Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia.
Momparler RL. Momparler RL. Exp Hematol Oncol. 2013 Aug 6;2:20. doi: 10.1186/2162-3619-2-20. eCollection 2013. Exp Hematol Oncol. 2013. PMID: 23919448 Free PMC article.
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2'-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza).
Momparler RL. Momparler RL. Pharmaceuticals (Basel). 2012 Aug 21;5(8):875-81. doi: 10.3390/ph5080875. Pharmaceuticals (Basel). 2012. PMID: 24280679 Free PMC article.
Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells.
Momparler RL, Côté S, Momparler LF, Idaghdour Y. Momparler RL, et al. Front Oncol. 2017 Feb 15;7:19. doi: 10.3389/fonc.2017.00019. eCollection 2017. Front Oncol. 2017. PMID: 28261562 Free PMC article.
Targeting of cancer stem cells by inhibitors of DNA and histone methylation.
Momparler RL, Côté S. Momparler RL, et al. Expert Opin Investig Drugs. 2015;24(8):1031-43. doi: 10.1517/13543784.2015.1051220. Epub 2015 May 25. Expert Opin Investig Drugs. 2015. PMID: 26004134 Review.
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.
Momparler RL, Côté S, Momparler LF, Idaghdour Y. Momparler RL, et al. Clin Epigenetics. 2014 Oct 1;6(1):19. doi: 10.1186/1868-7083-6-19. eCollection 2014. Clin Epigenetics. 2014. PMID: 25313314 Free PMC article.
Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine).
Momparler RL. Momparler RL. Front Oncol. 2013 Jul 29;3:188. doi: 10.3389/fonc.2013.00188. eCollection 2013. Front Oncol. 2013. PMID: 23908969 Free PMC article.
126 results
Jump to page
Feedback